Bronchoalveolar lavage for the evaluation of interstitial lung disease: Is it clinically useful?

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 761-769

  Meyer, K C ^a   Raghu, G ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bronchoalveolar lavage; Interstitial lung disease

Indexed keywords

BRONCHOSCOPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL PROTOCOL; CONSENSUS DEVELOPMENT; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG CANCER; LUNG INFECTION; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SENSITIVITY ANALYSIS;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; LUNG DISEASES, INTERSTITIAL; UNNECESSARY PROCEDURES;

EID: 80053557379     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00069509     Document Type: Review

References (71)

1. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001; 7: 255-261. (Pubitemid 32929679)
2. Costabel U, Guzman J. Bronchoalveolar lavage. In: Schwartz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, BC Decker, 2003; pp. 114-133.
3. Drent M, Meyer KC, Baughman RP. Bronchoalveolar lavage. Prog Respir Res 2007; 36: 58-67.
4. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990; 3: 937-976.
5. The BAL Co-operative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141: Suppl. 5, S169-S202.
6. Haslam PL, Baughmann RP, eds. Guidelines for the measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 1999; 9: 25-157.
7. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 2007; 28: 546-560. (Pubitemid 350036965)
8. Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in the evaluating the patient with known or suspected ILD. Semin Roentgenol 2010; 45: 3.
9. Schmidt SL, Sundaram B, Flaherty KR. Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis? Respirology 2009; 14: 934-939.
10. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-249.
11. Baughman RP. Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 2007; 28: 475-485. (Pubitemid 350036958)
12. Martin TR, Raghu G, Maunder RJ, et al. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis 1985; 132: 254-260. (Pubitemid 15229376)
13. Dhillon DP, Haslam PL, Townsend PJ, et al. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery. Eur J Respir Dis 1986; 68: 341-350.
14. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J 1992; 5: 776-779.
15. Meyer KC. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Aging Develop 1998; 104: 169-181. (Pubitemid 28457047)
16. Meyer KC, Soergel P. Bronchoalveolar lymphocyte phenotypes change in the normal aging human lung. Thorax 1999; 54: 697-700. (Pubitemid 29341406)
17. Dohn MN, Baughman RP. Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis 1985; 132: 390-392. (Pubitemid 15229401)
18. Helmers RA, Dayton CS Floerchinger C, et al. Bronchoalveolar lavage in interstitial lung disease: effect of volume of fluid infused. J Appl Physiol 1989; 67: 1443-1446. (Pubitemid 19276396)
19. Baughman RP, Drent M. Role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2001; 22: 331-341. (Pubitemid 32579068)
20. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2004; 25: 637-649. (Pubitemid 39556500)
21. Baughman RP. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Pro: bronchoalveolar lavage. J Bronchology 1999; 6: 211-216. (Pubitemid 30263262)
22. Raghu G. Is bronchoalveolar lavage clinically useful for everyday practice in interstitial lung disease? Con: bronchoalveolar lavage. J Bronchology 1999; 6: 217-221. (Pubitemid 30263263)
23. Poletti V, Poletti G, Murer B, et al. Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 2007; 28: 534-545. (Pubitemid 350036964)
24. Welker L, Jörres RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of intnerstitial lung diseases. Eur Respir J 2004; 24: 1000-1006. (Pubitemid 39642292)
25. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150: 1423-1438. (Pubitemid 24356662)
26. Pope-Harman AL, Davis WB, Allen ED, et al. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996; 75: 334-342. (Pubitemid 27009235)
27. Drent M, Jacobs JA. Bronchoalveolar lavage. In: Baughman RP, Du Bois RM, Lynch JP III, et al., eds. Diffuse Lung Disease: A Practical Approach. New York, Oxford University Press, 2004: pp. 56-64.
28. Fontenot AP, Schwarz MI. Diffuse alveolar hemorrhage. In: Schwartz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, BC Decker, 2003: pp. 632-656.
29. Martin RJ, Coalson JJ, Rogers RM, et al. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980; 121: 819-825. (Pubitemid 10096714)
30. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 2007; 28: 486-495. (Pubitemid 350036959)
31. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-432.
32. Costabel U, Zaiss AW, Guzman J. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9: Suppl. 1, 211-214.
33. Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104: 252-261.
34. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997; 10: 2716-2721. (Pubitemid 28052776)
35. Auerswald U, Barth J, Magnussen H. Value of CD1 positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1990; 169: 305-309.
36. Costabel U, Guzman J, Bonella F, et al. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 2007; 28: 514-524. (Pubitemid 350036962)
37. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
38. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124: 1215-1223. (Pubitemid 37290029)
39. Lynch DA, Godwin D Jr, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488-493. (Pubitemid 41117395)
40. Swensen SJ, Aughenbaugh GL, Myers JL. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology 1997; 205: 229-234. (Pubitemid 27415153)
41. Mathieson JR, Mayo JR, Staples CA, et al. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171: 111-116. (Pubitemid 19093054)
42. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
43. Raghu G. Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011. Eur Respir J 2011; 37: 743-746.
44. Ohshimo S, Bonella F, Cui A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 1043-1047.
45. Haslam PL, Dewar A, Butchers P, et al. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveoliltis. Comparison with other interstitial lung diseases. Am Rev Respir Dis 1987; 135: 35-47. (Pubitemid 17223886)
46. Drent M, van Velzen-Blad H, Diamant M, et al. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J 1993; 6: 1276-1281. (Pubitemid 23329542)
47. Lynch JPD, Standiford TJ, Rolfe MW, et al. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-1439.
48. Haslam PL, Turton CW, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35: 328-339.
49. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981; 124: 1-8. (Pubitemid 11079332)
50. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704. (Pubitemid 17041608)
51. Peterson WMW, Monick M, Hunniknghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987; 92: 51-56. (Pubitemid 17101335)
52. Drent M, Jacobs JA, De Vries J, et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999; 13: 1338-1344. (Pubitemid 29357150)
53. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454. (Pubitemid 24068994)
54. Ryu YJ, Chung MP, Han J, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007; 101: 655-660. (Pubitemid 46196313)
55. Kylstra JA, Rausch DC, Hall KD, et al. Volume-controlled lung lavage in the treatment of asthma, bronchiectasis, and mucoviscidosis. Am Rev Respir Dis 1971; 103: 651-665.
56. Ramirez J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med 1963; 112: 419-431.
57. Huizar I, Kavuru MS. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management. Curr Opin Pulm Med 2009; 15: 491-498.
58. Agostini C, Miorin M, Semenzato G. Gene expression profile analysis by DNA microarrays: a new approach to assess functional genomics in diseases. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 5-9. (Pubitemid 34298488)
59. Kaminski N, Rosas IO. Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes? Proc Am Thorac Soc 2006; 3: 339-344. (Pubitemid 43852873)
60. Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest 2006; 130: 567-574. (Pubitemid 44267028)
61. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004; 170: 242-251. (Pubitemid 38971408)
62. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002; 99: 6292-6297. (Pubitemid 34493305)
63. Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PloS Med 2005; 2: e251.
64. Thonhofer R, Maercker C, Popper HH. Expression of sarcoidosis related genes in lung lavage cells. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 5-9.
65. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006; 173: 188-198. (Pubitemid 43187891)
66. Lenz AG, Meyer B, Costabel U, et al. Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis. Electrophoresis 1993; 14: 242-244. (Pubitemid 23116197)
67. Uebelhoer M, Bewig B, Oldigs M, et al. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis. Scand J Clin Lab Invest 1993; 53: 617-623. (Pubitemid 23311143)
68. Wattiez R, Hermans C, Cruyt C, et al. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000; 21: 2703-2712.
69. Magi B, Bini L, Perari MG, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 2002; 23: 3434-3444. (Pubitemid 35230229)
70. Rottoli P, Magi B, Perari MG, et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5: 1423-1430.
71. De Torre C, Ying S, Munson PJ, et al. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 2006; 6: 3949-3957. (Pubitemid 44081167)